Intermediate vancomycin resistance in Staphylococcus aureus: a major threat or a minor inconvenience?
Johnson
A P
AP
Antibiotic Reference Unit, Central Public Health Laboratory, Colindale, London, UK. ajohnson@phls.co.uk
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D006801:Humans; D008826:Microbial Sensitivity Tests; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus / Q000187:drug effects*; D014640:Vancomycin / Q000494:pharmacology / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D014640:Vancomycin